DTAP + HEP B + IPV (PEDIARIX) VACCINE

VACCINE USAGE: PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday).

VACCINE DOSAGE: Immunization with PEDIARIX consists of 3 doses of 0.5 mL each, by intramuscular injection, at 2, 4, and 6 months of age (at intervals of 6 to 8 weeks, preferably 8 weeks). The first dose may be given as early as 6 weeks of age. Three doses of PEDIARIX constitute a primary immunization course for diphtheria, tetanus, pertussis, and poliomyelitis and the complete vaccination course for hepatitis B.

VACCINE INGEDIENTS: formaldehyde, glutaraldehyde, aluminum hydroxide, aluminum phosphate, lactalbumin hydrolysate, polysorbate 80, neomycin sulfate, polymyxin B, yeast protein, calf serum, Fenton medium (containing bovine extract), modified Latham medium (derived from bovine casein), modified Stainer-Scholte liquid medium, Vero (monkey kidney) cells.

ADVERSE VACCINE REACTIONS: pyrexia, gastroenteritis, bronchiolitis, Sudden infant death syndrome (SIDS), convulsive disorder, congenital immunodeficiency with sepsis, neuroblastoma, by chance alone some cases of SIDS can be expected to follow receipt of pertussis- containing vaccines. Chronic illness, asthma, febrile and afebrile seizures, infantile spasms, jaundice, meningitis, lichen planus.